EQUAL Score Scedosporiosis/Lomentosporiosis 2021: a European Confederation of Medical Mycology (ECMM) tool to quantify guideline adherence.

EQUAL Score Scedosporiosis/Lomentosporiosis 2021: a European Confederation of Medical Mycology (ECMM) tool to quantify guideline adherence.
复制标题

DOI:
10.1093/jac/dkab355
复制
发表时间:
2021-12-24
期刊:
The Journal of antimicrobial chemotherapy
影响因子:
--
通讯作者:
Cornely OA
Cornely OA
中科院分区:
其他
文献类型:
--
作者:
Stemler J;Lackner M;Chen SC;Hoenigl M;Cornely OA

文献摘要

参考文献

被引文献

相似文献

Invasive scedosporiosis and lomentosporiosis are life-threatening fungal infections in immunocompromised patients with complex diagnostic and treatment patterns. To develop a scoring tool to facilitate and quantify adherence to current guideline recommendations for diagnosis, treatment and follow-up of invasive scedosporiosis and lomentosporiosis. Experts from European Confederation of Medical Mycology (ECMM) excellence centres reviewed current guidelines for scedosporiosis and lomentosporiosis. Recommendations for diagnosis, treatment and follow-up were summarized, assembled and weighted according to their strength of recommendation and level of evidence (strongly recommended = 3 points; moderately recommended = 2 points; marginally recommended = 1 point; recommended against = 0 points). Additional items considered of high importance for clinical management were also weighted. A total of 170 recommendations were identified. A 21-item tool was developed and embedded into the EQUAL score card. Nine items for diagnosis with 18 achievable points were assembled. For treatment, three general recommendation items with a maximal score of 9 were identified, while for specific antifungal treatment the two fungal pathogens were separated. Three and four items were established for scedosporiosis and lomentosporiosis, respectively, with a maximum achievable score of 3 due to the separation of different treatment options with the maximum point value of 3 for voriconazole-based treatment. Follow-up comprised two items (4 points maximum). Key recommendations for clinical outcome were weighted accordingly. We propose the EQUAL Score Scedosporiosis/Lomentosporiosis to quantify adherence to current guideline recommendations for management of these rare infections. The score remains to be validated in real-life patient cohorts and correlated with patient outcome.
DOI: 10.1016/j.cmi.2020.01.029
发表时间: 2020-11-01
影响因子: 14.2
作者:
Huang, Ho-Yin;Lu, Po-Liang;Lin, Shang-Yi
通讯作者: Lin, Shang-Yi
DOI: 10.1111/ctr.13544
发表时间: 2019-09-01
影响因子: 2.1
作者:
Husain, Shahid;Camargo, Jose F.
通讯作者: Camargo, Jose F.
DOI: 10.1016/j.cmi.2020.01.012
发表时间: 2020-06-01
影响因子: 14.2
作者:
Jenks, J. D.;Seidel, D.;Hoenigl, M.
通讯作者: Hoenigl, M.
DOI: 10.1111/myc.13076
发表时间: 2020-04-13
期刊: MYCOSES
影响因子: 4.9
作者:
Koehler, Philipp;Denis, Blandine;Cornely, Oliver A.
通讯作者: Cornely, Oliver A.
DOI: 10.1093/jac/dkw532
发表时间: 2017-04-01
影响因子: 5.2
作者:
Martin-Vicente, Adela;Guarro, Josep;Capilla, Javier
通讯作者: Capilla, Javier